The Korean journal of pain · 2026
Aggrecan and small leucine-rich proteoglycan fragments correlate with Toll-like receptor-2 mediated inflammation in painful degenerative disc disease.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lama Polly, Tamang Binod Kr, Tiwari Jerina, Chakraborty Sagnik, Chauhan Sukriti, Adams Michael A
Аннотация
BACKGROUND: Painful intervertebral disc degeneration is a leading cause of chronic low back pain. Proteolytic cleavage fragments of extracellular matrix components, particularly aggrecan and small leucine-rich proteoglycans (SLRPs), may act as endogenous danger signals activating inflammatory pathways. To determine whether proteolytic fragments of aggrecan and SLRPs correlate with disc degeneration severity and Toll-like receptor-2 (TLR-2) mediated inflammation.
METHODS: Human disc tissues were analysed from 20 non-degenerated cadaveric controls (Thompson Grades 1-2) and 35 patients with painful degeneration (Pfirrmann Grades 3-5). Western blotting assessed fragmentation of aggrecan and SLRPs (decorin, biglycan, lumican, fibromodulin, chondroadherin). Immunofluorescence localized these molecules in disc sections. Disc cells were cultured under four conditions: unstimulated controls, TLR-2 agonist Pam2CSK4-stimulated controls, cells extracted from degenerated discs, and those treated with the TLR-2 antagonist MMG-11. Cytokine profiles were determined using antibody array.
RESULTS: Fragmented peptides of aggrecan and SLRPs (22-45 kDa) were predominantly detected in Pfirrmann Grades 4 and 5 discs. TLR-2 expression was significantly higher in degenerated disc cells versus controls (P < 0.001), further upregulated by Pam2CSK4 and attenuated by MMG-11. Cytokine analysis revealed marked pro-inflammatory shifts in patient discs (interleukin [IL]-6 ↑1.37×, IL-8 ↑1.30×, IL-1β ↑1.25×), while control discs exhibited an anabolic profile with elevated expressions of growth factors (TGF-β, EGF, VEGF).
CONCLUSIONS: Aggrecan and SLRP fragments were observed alongside TLR-2 mediated inflammatory responses in advanced disc degeneration, suggesting a potential association with tissue catabolism. Targeting TLR-2 signaling may warrant further investigations as a potential therapeutic strategy for painful disc disease.
METHODS: Human disc tissues were analysed from 20 non-degenerated cadaveric controls (Thompson Grades 1-2) and 35 patients with painful degeneration (Pfirrmann Grades 3-5). Western blotting assessed fragmentation of aggrecan and SLRPs (decorin, biglycan, lumican, fibromodulin, chondroadherin). Immunofluorescence localized these molecules in disc sections. Disc cells were cultured under four conditions: unstimulated controls, TLR-2 agonist Pam2CSK4-stimulated controls, cells extracted from degenerated discs, and those treated with the TLR-2 antagonist MMG-11. Cytokine profiles were determined using antibody array.
RESULTS: Fragmented peptides of aggrecan and SLRPs (22-45 kDa) were predominantly detected in Pfirrmann Grades 4 and 5 discs. TLR-2 expression was significantly higher in degenerated disc cells versus controls (P < 0.001), further upregulated by Pam2CSK4 and attenuated by MMG-11. Cytokine analysis revealed marked pro-inflammatory shifts in patient discs (interleukin [IL]-6 ↑1.37×, IL-8 ↑1.30×, IL-1β ↑1.25×), while control discs exhibited an anabolic profile with elevated expressions of growth factors (TGF-β, EGF, VEGF).
CONCLUSIONS: Aggrecan and SLRP fragments were observed alongside TLR-2 mediated inflammatory responses in advanced disc degeneration, suggesting a potential association with tissue catabolism. Targeting TLR-2 signaling may warrant further investigations as a potential therapeutic strategy for painful disc disease.